We have located links that may give you full text access.
Effects of Qi-Fang-Xi-Bi-Granules on Cartilage Morphology and C/ebp α Promoter Methylation in Rats with Knee Osteoarthritis.
Objective: To investigate the effects of Qi-Fang-Xi-Bi-Granules (QFXBGs) on cartilage morphology and methylation of C/ebp α (CCAAT/enhancer binding protein α ) at the promoter region.
Methods: Knee osteoarthritis (KOA) modeling was performed in rats in accordance with Hulth's method, and control group received sham operation. Eight weeks after KOA modeling, the rats in the KOA modeling group were further divided into 6 groups. Each group was given the appropriate drug. After 8 weeks, half of the rats were used for Micro-CT scan, HE staining, ABH/OG staining, immunohistochemistry, and TUNNEL staining of the knee joint tissue, and the other half were used to examine C/ebp α promoter methylation.
Results: The three dose groups of QFXBGs all showed lower degrees of surface fissures and flaking, thicker cartilage layer, and restored chondrocyte and subchondral bone morphology, compared with the KOA model group. C/ebp α -22 promoter methylation levels in the high- and low-dose groups were significantly higher than that in the KOA modeling group ( p < 0.05), while C/ebp α -2 promoter methylation level in the medium-dose group was significantly higher than that in the KOA modeling group ( p < 0.05).
Conclusions: QFXBGs may alleviate articular cartilage degeneration through promoting C/ebp α -2 or C/ebp α -22 methylation at specific promoter sites.
Methods: Knee osteoarthritis (KOA) modeling was performed in rats in accordance with Hulth's method, and control group received sham operation. Eight weeks after KOA modeling, the rats in the KOA modeling group were further divided into 6 groups. Each group was given the appropriate drug. After 8 weeks, half of the rats were used for Micro-CT scan, HE staining, ABH/OG staining, immunohistochemistry, and TUNNEL staining of the knee joint tissue, and the other half were used to examine C/ebp α promoter methylation.
Results: The three dose groups of QFXBGs all showed lower degrees of surface fissures and flaking, thicker cartilage layer, and restored chondrocyte and subchondral bone morphology, compared with the KOA model group. C/ebp α -22 promoter methylation levels in the high- and low-dose groups were significantly higher than that in the KOA modeling group ( p < 0.05), while C/ebp α -2 promoter methylation level in the medium-dose group was significantly higher than that in the KOA modeling group ( p < 0.05).
Conclusions: QFXBGs may alleviate articular cartilage degeneration through promoting C/ebp α -2 or C/ebp α -22 methylation at specific promoter sites.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app